These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1583350)

  • 1. Evaluation of mucinous carcinoma associated antigen (MCA) levels in patients with breast cancer.
    Migali E; Ozzola G; Mariotti D; Ghezzi P; Rinaldini M; Magnanini S
    Int J Biol Markers; 1992; 7(1):61-4. PubMed ID: 1583350
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
    Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
    Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEA, TPA and CA 15.3 in tissue and serum of breast cancer patients.
    Saccani Jotti G; Grassi C; Fontanesi M; Becchi G; Gion M
    Int J Biol Markers; 1992; 7(4):265-6. PubMed ID: 1491185
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.
    Boccardo F; Bombardieri E; Zanardi S; Valenti G; Zanaboni F; Valtolina M; Seregni E; Crippa F
    Int J Biol Markers; 1991; 6(1):12-20. PubMed ID: 1856512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 549 as a marker in breast cancer.
    Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Dorsa R; Schwartz DC
    Int J Biol Markers; 1991; 6(3):139-43. PubMed ID: 1791307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of mucinous carcinoma-associated antigen (MCA) tests in breast carcinomas.
    Günes I; Miserez AR; Müller-Brand J; Maecke H
    Int J Biol Markers; 1992; 7(4):222-4. PubMed ID: 1491177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPS in breast cancer--a comparative study with carcinoembryonic antigen and CA 15-3.
    van Dalen A
    Tumour Biol; 1992; 13(1-2):10-7. PubMed ID: 1589693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the new tumor marker MCA in the follow-up of patients with mammary carcinoma.
    Müller-Brand J; Mäcke H
    Int J Biol Markers; 1993; 8(2):130-2. PubMed ID: 8366296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
    Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
    Steger GG; Mader R; Derfler K; Moser K; Dittrich C
    Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoembryonic antigen (CEA) and mucinous-like tumor associated antigen (MAC). Statistic correlation in advanced breast carcinoma].
    Sbalzarini G; D'Agostino F; Mercantini F; Girami M; Labadini A; Pandolfi C
    Minerva Med; 1991 Dec; 82(12):811-3. PubMed ID: 1780086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
    Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
    Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum (circulating) tumor markers for breast cancer.
    Hayes DF
    Recent Results Cancer Res; 1996; 140():101-13. PubMed ID: 8787054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
    Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D
    Am J Clin Oncol; 1996 Oct; 19(5):459-64. PubMed ID: 8823487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study.
    Martoni A; Zamagni C; Bellanova B; Zanichelli L; Vecchi F; Cacciari N; Strocchi E; Pannuti F
    Eur J Cancer; 1995 Sep; 31A(10):1615-21. PubMed ID: 7488411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor markers in metastatic breast carcinoma: correlations with clinical response].
    Winer Y; Martini MC; Pastorino G; Moraglio L; Vallauri M; Brondi P; Brema F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):127-30. PubMed ID: 2092107
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple method for comparing reliability of two serum tumour markers in breast carcinoma.
    O'Brien DP; Gough DB; Skehill R; Grimes H; Given HF
    J Clin Pathol; 1994 Feb; 47(2):134-7. PubMed ID: 8132827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CA M26, CA M29, CA 15-3 and CEA as circulating tumor markers in breast cancer patients.
    Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
    Tumour Biol; 1991; 12(2):82-90. PubMed ID: 2028182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumour markers of pancreatic cancer (tumour associated antigens)].
    Groblewska M; Mroczko B; Szmitkowski M
    Pol Arch Med Wewn; 2005 Jun; 113(6):585-93. PubMed ID: 16454450
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of mucinous-like carcinoma associated antigen (MCA) in breast pathology: comparison with carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA).
    Saccani Jotti G; Fontanesi M; Colombo A; Valtolina M; Tardini A
    Int J Biol Markers; 1990; 5(3):145-52. PubMed ID: 2286779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.